Analysis of different doses of intravenous dexmedetomidine in decreasing shivering in patients undergoing planned caesarean delivery under central neuraxial anaesthesia.

Evaluation of varied doses of Intravenous Dexmedetomidine in attenuating post spinal anesthesia shivering response in patients undergoing Elective Lower Segment Cesarean Section - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/068112

Enrollment

Registered

2024-05-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O895- Other complications of spinal andepidural anesthesia during the puerperium

Interventions

Intervention1: Dexmedetomidine: Intravenous dexmedetomidine 0.2 mcg/kg body weight will be administered once over 10 minutes. Control Intervention1: Dexmedetomidine: Intravenous dexmedetomidine 0.5 mc

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 2 patients above 18 years of age who shiver during elective LSCS that continued to cord clamping

Exclusion criteria

Exclusion criteria: Unscheduled caesarean deliveries History of chronic nausea or itching in pregnancy Chronic opioid use History of cardiac, renal or hepatic disease requiring follow up or medications Coagulation disorders History of febrile illness

Design outcomes

Primary

Measure	Time frame
Shivering score will be measured according to crossley and mahajan grading for shiveringTimepoint: At 5 minutes interval till 15 minutes and then at 30 minutes and 60 minutes	—

Secondary

Measure	Time frame
Sedation scoreTimepoint: At 5 minutes interval till 15 minutes and then at 30 minutes and 60 minutes	—

Countries

India

Contacts

Public ContactDr Vinay Kejdiwal

Kasturba Medical College, Manipal

shweta1987.SS95@gmail.com8879056117

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026